MetLife Investment Management’s BlueLinx BXC Stock Holding History
Bought
Maintained
Sold
Other funds holding BXC
GJL
JCP
VCM
PAIM
RRAM
MetLife Investment Management's BXC Position: Q1 2026 in Review
MetLife Investment Management increased its BlueLinx (BXC) stake by 4.9% in Q1 2026, buying an estimated $14.6K and bringing the position to 4,782 shares worth $259K. The position accounts for ﹤0.01% of the portfolio, ranked #2088.
MetLife Investment Management first reported a position in BXC in Q2 2018 and has held it in 23 quarters since. The position peaked at $594K in Q1 2024. 145 funds tracked by Wall St. Rank hold BXC as of Q1 2026.
- MetLife Investment Management held 4,782 shares of BlueLinx worth $259K as of Q1 2026.
- MetLife Investment Management bought 223 BlueLinx shares in Q1 2026, an estimated $14.6K.
- BlueLinx made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2088 holding.
- MetLife Investment Management first reported a position in BlueLinx in Q2 2018 and has held it in 23 quarters since.
- MetLife Investment Management's BlueLinx position peaked at $594K in Q1 2024.
- 145 funds tracked by Wall St. Rank held BlueLinx as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.